Epidemiology and Evaluation

Research group

Group Leader

Maria Sala Serra

This is a group with multidisciplinary training (epidemiology, health economy, statistics and nursing) which has carried out research activity in the field of health services research (HSR), specifically in the evaluation of the effectiveness and costs of health services and interventions; the evaluation of the needs and use of health services; and the development of instruments for HSR. Current research lines are centered mainly on the evaluation of the health care process in cancer patients, focusing on breast and colon cancer screening, and the process’s impact on survival.

Members

Marta Banqué Navarro (Researcher)

Andrea Buron Pust (Researcher)

Xavier Castells Oliveres (Researcher)

Pietro Chiarello (Technician)

Mercè Comas Serrano (Researcher)

Francesc Cots Reguant (Researcher)

Irene Fernández García (Research Assistant)

Priscila Giraldo Matamoros (Research Assistant)

Cristina Hernández Rodríguez (Technician)

Javier Louro Aldamiz-Echevarría (Technician)

Francesc Assís Macià Guilà (Researcher)

Esther Martínez Amor (Research Assistant)

Marta Riu Camps (Technician)

Marta Román Expósito (Researcher)

Ana Isabel Romero Morales (Technician)

Roser Terradas Robledo (Researcher)

 

more info

Main Publications

• Abulí A, Castells A, Bujanda L, Lozano JJ, Bessa X, Hernández C, Álvarez C, Pellisé M, Esteban-Jurado C, Hijona E, Burón A, Macià F, Grau J, Guayta R, Castellví-Bel S, Andreu M, PROCOLON research group. Genetic Variants Associated with Colorectal Adenoma Susceptibility. PLoS ONE 2016; 11(4): e0153084. IF 3.057. Q1.

• Castells X, Torá-Rocamora I, Posso M, Román M, Domingo L, Vidal C, Ferrer J, Quintana MJ, Sánchez M, Saladie F, Sala M, for the BELE Study Group. Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features. Radiology 2016; 280(2): 379-386. IF 6.798. Q1.

• Cots F, Chiarello P, Pérez V, Garcia A, Becerra V. Hospital Costs Associated With Agitation in the Acute Care Setting. Psychiat Serv 2016; 67(1): 124-127. IF 2.335. Q1.

• Cubiella J, Carballo F, Portillo I, Cruzado J, Salas D, Binefa G, Milà N, Hernández C, Andreu M, Terán Á, Arana-Arri E, Ono A, Valverde MJ, Bujanda L, Hernández V, Morillas JD, Jover R, Castells A. Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines. Endoscopy 2016; 48(11): 995-1002. IF 5.634. Q1.

• Domingo L, Hofvind S, Hubbard R, Román M, Benkeser D, Sala M, Castells X. Cross-national comparison of screening mammography accuracy measures in U.S., Norway, and Spain. Eur Radiol 2016; 26(8): 2520-2528. IF 3.64. Q1.

• Giraldo P, Sato L, Martínez-Sánchez JM, Comas M, Dwyer K, Sala M, Castells X. Eleven-year descriptive analysis of closed court verdicts on medical errors in Spain and Massachusetts. BMJ Open 2016; 6(8): e011644. IF 2.562. Q1.

• Giraldo P, Sato L, Sala M, Comas M, Dywer K, Castells X. A retrospective review of medical errors adjudicated in court between 2002 and 2012 in Spain. Int J Qual Health C 2016; 28(1): 33-39. IF 2.545. Q1.

• Guerrero R, Comas M, Espallargues M, Coll M, Pons M, Sabatés S, Allepuz A, Castells X. Predicting the Burden of Revision Knee Arthroplasty: Simulation of a 20-Year Horizon. Value Health 2016; 19(5): 680-687. IF 3.824. Q1.

• Guiriguet C, Muñoz-Ortiz L, Burón A, Rivero I, Grau J, Vela-Vallespín C, Vilarrubí M, Torres M, Hernandez C, Méndez-Boo L, Torán P, Caballería L, Macià F, Castells A. Alerts in electronic medical records to promote colorectal cancer screening programme: a cluster randomised controlled trial in primary care. Brit J Gen Pract 2016; 66(648): e483-e490. IF 2.741. Q1.

• Riu M, Chiarello P, Terradas R, Sala M, Garcia-Alzorriz E, Castells X, Grau S, Cots F. Cost Attributable to Nosocomial Bacteremia. Analysis According to Microorganism and Antimicrobial Sensitivity in a University Hospital in Barcelona. PLoS ONE 2016; 11(4): e0153076. IF 3.057. Q1.

Ongoing Research Projects

• Lesiones benignas de mama, densidad mamaria y asociación con el riesgo de cáncer en una cohorte de mujeres cribadas

− Fondo de Investigación Sanitaria. ISCIII (PI15/00098)

− From 2016 to 2018

− Principal investigator: Castells Oliveres, Xavier

 

• Effect of interval cancer and screening process on survival and disease-free interval in breast cancer

− Fondo de Investigación Sanitaria. ISCIII (PI12/00387)

− From 2013 to 2016

− Principal investigator: Sala Serra, Maria

Participation in Research Networks

• Research network on health services in chronical diseases – REDISSEC (Red de Investigación en Servicios de Salud en Enfermedades Crónicas)

− Fondo de Investigación Sanitaria. ISCIII. Subprograma RETICS. RD16/0001/0013

− Principal investigator: Sala Serra, Maria

 

• Research network on health services in chronical diseases – REDISSEC (Red de Investigación en Servicios de Salud en Enfermedades Crónicas)

− Fondo de Investigación Sanitaria. ISCIII. Subprograma RETICS. RD12/0001/0015

− Principal investigator: Sala Serra, Maria

Group’s Recognitions

• Officially recognised as a consolidated research group by the Generalitat de Catalunya: Servei d'Avaluació i Epidemologia Clínica (2014-2017)

− Agència de Gestió d’Ajuts Universitaris i de Recerca (SGR 427)

− Principal investigator: Castells Oliveres, Xavier

Clinical Trials Signed in 2016

• Prescripción potencialmente Inadecuada asociada a la Multimorbilidad en pacientes Crónicos agudizados, utilizando los criterios STOPP-START. Estudio PIMyC

− Fundació Parc Taulí

− From 2016 to 2017

− Principal investigators: Giraldo Matamoros, Priscila; Fernández Quirate, Oliva; De Jaime Gil, Elisabet

Theses

• Giraldo P. Legal aspects of the health strategy of patient safety. Autonomous University of Barcelona

− Directors: Castells, Xavier; Corbella i Duch, Josep

− Date of defense: 11/10/2016

 

• Corral J. Health services research in oncology: evaluation of the need for external radiotherapy based on the evidence and the cost of cancer treatment Autonomous University of Barcelona

− Directors: Cots, Francesc; Castells, Xavier; Borras, José M.

− Date of defense: 29/01/2016

Other

• Román M. Evaluation of mammographic screening: the evaluation of positive results, associated factors and their impact on screened women. Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida. Extraordinary Award for best PhD Thesis in Health presented at the University of Lleida (Spain). Directors: Castells, Xavier; Rué, Montserrat. Date of defense: 25/06/2015.

C/ Doctor Aiguader, 88

08003 Barcelona

(+34) 93 316 04 00

info@imim.es